Oncology Research Reports & Consulting

Browse reports
DataM has exclusive market relevance and knowledge catering our services in 60+ industries
SUB CATEGORIES
FILTER
Geography
Publish Date
Themesdown
SORT
Upload Date
Upload Date
Price
Published: 2025 June 23
Thymus Cancer Market Size, Share, Industry, Forecast and Outlook (2025-2033)
In 2023, the global thymus cancer was valued at US$ 4.82 Billion. The global thymus cancer market size reached US$ 5.03 Billion in 2024 and is expected to reach US$ 7.80 Billion by 2033
Starting from
$4350$3480
Published: 2026 August 11
Oncology Therapy Market Size, Share, Growth Trends & Forecast 2035
Oncology therapy market reached USD 212.6 billion in 2025 and is forecast to reach USD 531.7 billion by 2035, growing at a 9.6% CAGR.
Starting from
$4350$3480
Published: 2026 August 17
Chronic Lymphocytic Leukemia Therapeutics Market Size, Share, Targeted Therapy Trends and Forecast 2035
Chronic lymphocytic leukemia therapeutics market reached USD 6.01 billion in 2025 and is forecast to reach USD 10.27 billion by 2035 at a 5.5% CAGR.
Starting from
$4350$3480
Published: 2025 July 08
Cancer Vaccines Market Size, Share, Industry, Forecast and outlook (2025-2033)
The global cancer vaccines market reached US$ 8.82 Billion in 2023, with a rise of US$ 9.27 Billion in 2024 and is expected to reach US$ 14.96 Billion by 2033
Starting from
$4350$3480
Published: 2024 October 23
T-cell-lymphoma Market Size, Share, Industry, Forecast and outlook (2024-2031)
T-cell-lymphoma Market is expected to grow at a CAGR of 8.4% during the forecast period 2024-2031 | DataM Intelligence
Starting from
$4350$3480
Published: 2026 August 26
Myelofibrosis Therapeutics Market Size, Share, JAK Inhibitor & Pipeline Trends and Forecast 2026–2035
Myelofibrosis Therapeutics market reached US$ 1.7 billion in 2025 and is projected to reach US$ 3.48 billion by 2035 at 7.6% CAGR, driven by JAK inhibitors, anemia therapies and non-JAK pipelines.
Starting from
$4350$3480
Published: 2024 May 20
Insulinoma Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031)
Insulinoma Treatment Market is expected to grow at a high CAGR during the forecast period 2024-2031 | DataM Intelligence
Starting from
$4350$3480
Published: 2025 October 16
Tyrosine Kinase Inhibitors Market Size, Share & Trends (2025–2033) | Growth at 6.4% CAGR
The global Tyrosine Kinase Inhibitors Market reached USD 53.99 Billion in 2024 and is projected to hit USD 93.97 Billion by 2033, growing at a CAGR of 6.4%. Discover insights on market segmentation, leading drugs like Imatinib & Osimertinib, regional analysis (North America, APAC), and key players including Roche, Thermo Fisher, and Siemens Healthineers.
Starting from
$4350$3480
Published: 2026 April 27
Diffuse Large B-cell Lymphoma Therapeutics Market Size, Share Analysis, Growth Trends and Forecast 2026-2033
Diffuse Large B-cell Lymphoma Therapeutics Market grows from USD 5.70B in 2025 to USD 9.94B by 2033 at 7.50% CAGR during 2026-2033
Starting from
$4350$3480
Published: 2024 January 10
Brachytherapy Market Size, Share, Industry, Forecast and outlook (2024-2031)
Global Brachytherapy Market is expected to grow at a CAGR of 8.1% during the forecast period 2024-2031
Starting from
$4350$3480